ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,071.63
0.02%
US Tech 100
17,060.40
0.00%
Dow Jones
38,460.92
-0.11%
Brent Oil
87.385
0.19%
Bitcoin
64,291.78
0.02%
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Scholar Rock Holdings Corporation (SRRK) Quote

Scholar Rock Holdings Corporation

Scholar Rock Holdings Corporation (SRRK)

NASDAQ
14.09
0.00
(0.00%)
Closed April 25 4:00PM
Delayed by 15 minutes
0.00
0.00
(0.00%)
After Hours: -
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
14.09
Bid
12.50
Ask
14.93
Volume
-
0.00 Day's Range 0.00
5.56 52 Week Range 21.17
Market Cap
1.019B
Previous Close
14.09
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
818,367
Shares Outstanding
72,143,258
Dividend Yield
-
PE Ratio
-6.14
Earnings Per Share (EPS)
-2.3
Revenue
-
Net Profit
-165.79M

About Scholar Rock Holdings Corporation

Scholar Rock Holding Corp is a biopharmaceutical company. It is engaged in the discovery and development of innovative medicines for the treatment of serious diseases including neuromuscular disorders, cancer, fibrosis, and anemia. Geographically, the company primarily operates in the United States.... Scholar Rock Holding Corp is a biopharmaceutical company. It is engaged in the discovery and development of innovative medicines for the treatment of serious diseases including neuromuscular disorders, cancer, fibrosis, and anemia. Geographically, the company primarily operates in the United States. The company's lead product candidate is SRK-015 which is a highly selective, fully human, monoclonal antibody, with a mechanism of action that results in inhibition of the activation of the growth factor, myostatin, in skeletal muscle. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.scholarrock.com
Headquarters
Wilmington, Delaware, USA
Founded
1970
Scholar Rock Holdings Corporation is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker SRRK. The last closing price for Scholar Rock was $14.09. Over the last year, Scholar Rock shares have traded in a share price range of $ 5.56 to $ 21.17.

Scholar Rock currently has 72,143,258 shares outstanding. The market capitalization of Scholar Rock is $1.02 billion. Scholar Rock has a price to earnings ratio (PE ratio) of -6.14.

SRRK Latest News

More News

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Scholar Rock (NASDAQ: SRRK; the “Company”), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy, cardiometabolic disorders, and other...

April 12 2024
Business Wire

Scholar Rock Reports Full Year 2023 Financial Results and Highlights Business Progress

- Pivotal Phase 3 SAPPHIRE trial in patients with Spinal Muscular Atrophy on track to report topline data in 4Q 2024 - Announced FDA clearance of IND application to initiate Phase 2...

March 19 2024
Business Wire

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Scholar Rock (NASDAQ: SRRK; the “Company”), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy, cardiometabolic disorders, and other...

March 15 2024
Business Wire

Scholar Rock to Participate in Upcoming Investor Conferences

Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious...

February 28 2024
Business Wire

Form 4 - Statement of changes in beneficial ownership of securities

February 20 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

February 20 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

February 20 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

February 20 2024
Edgar (US Regulatory)

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Scholar Rock (NASDAQ: SRRK; “The Company”), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and...

February 16 2024
Business Wire

Form 3 - Initial statement of beneficial ownership of securities

February 15 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.392.8467153284713.715.1313.1871355614.13533296CS
4-3.1-18.033740546817.1917.913.1165658814.93888577CS
120.010.071022727272714.0817.912.8181836715.49791676CS
265.6366.5484633578.4621.178.3588783115.41836668CS
526.8293.81017881717.2721.175.5666094412.79592981CS
156-20.91-59.74285714293544.954.32548311312.70577208CS
260-3.83-21.372767857117.92704.32544670120.32706201CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAGRAfrican Agriculture Holdings Inc
$ 0.3999
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 60.2684
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.78
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.5001
(0.00%)
0
AACGATA Creativity Global
$ 0.87
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.3999
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 60.2684
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.78
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.5001
(0.00%)
0
AACGATA Creativity Global
$ 0.87
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.3999
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 60.2684
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.78
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.5001
(0.00%)
0
AACGATA Creativity Global
$ 0.87
(0.00%)
0

SRRK Discussion

View Posts
retireat40 retireat40 6 months ago
Wow. Now a $7 stock
👍️0
georgie18 georgie18 2 years ago
SRRK...$34.75...on the 100ma break...:party:
[11:57 AM]
georgie18 — 10/29/2021
SRRK...$27.34...Bullish Doji Star Reversal Pattern to the Upside as the Psar flipped Bullish...

Pincher Squeeze in play here...as the MACD Crosses Positive...Looking for a $40 Break/Hold...imo...we shall see...:party:
👍️0
georgie18 georgie18 2 years ago
SRRK...$28.45...Lets see if we can Break/Hold the Upper Band today...as the Bollie Squeeze sets up here...imo...We shall see...:party:
[4:32 AM]
georgie18 — 10/29/2021
SRRK...$27.34...Bullish Doji Star Reversal Pattern to the Upside as the Psar flipped Bullish...

Pincher Squeeze in play here...as the MACD Crosses Positive...Looking for a $40 Break/Hold...imo...we shall see...:party:
👍️0
georgie18 georgie18 2 years ago
SRRK...$27.34...Bullish Doji Star Reversal Pattern to the Upside as the Psar flipped Bullish...

Pincher Squeeze in play here...as the MACD Crosses Positive...Looking for a $40 Break/Hold...imo...we shall see...

Played this in the spring for nice profits...Back in again on this Pattern...

Chart... https://schrts.co/HtbEtPcc ...
👍️0
georgie18 georgie18 3 years ago
SRRK...$31.62...on the 50ma Break to the Upside...:party:
[6:26 AM]
georgie18 — 05/24/2021
SRRK...$28.75...Took a starter on the Bullish Harami today...:party:
👍️0
georgie18 georgie18 3 years ago
SRRK...$29.69...in the P/M...https://finance.yahoo.com/news/scholar-rock-presents-topaz-phase-113000823.html ...:party:
👍️0
stockguard stockguard 3 years ago
We`ll be back to higher highs soon.
👍️0
georgie18 georgie18 3 years ago
SRRK...$28.75...Took a starter on the Bullish Harami today...CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Scholar Rock (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for apitegromab, a selective inhibitor of myostatin activation, for the treatment of patients with Spinal Muscular Atrophy (SMA). Fast Track designation is intended to facilitate the development and expedite the review of drugs to treat serious conditions and get new drugs to patients earlier. Through Fast Track, Scholar Rock is eligible to submit a rolling Biologic License Application (BLA) for apitegromab if relevant criteria are met...
👍️0
stockguard stockguard 3 years ago
Scholar Rock Receives Fast Track Designation from the U.S. FDA for Apitegromab for the Treatment of Patients with Spinal Muscular Atrophy
https://www.businesswire.com/news/home/20210524005771/en/
👍️0
stockguard stockguard 3 years ago
Scholar Rock weakness overdone after TOPAZ results, says JPMorgan
JPMorgan analyst Anupam Rama noted that Scholar Rock shares are down about 15%, which Rama views as "overdone," after the company announced update 12-month results from the phase 2 TOPAZ study in the treatment of Type 2/3 Spinal Muscular Atrophy. The 12-month data showed relatively consistent functional benefit compared to six-month interim data reported in October, noted Rama, who added that "there were no major concerns" on the safety front. The analyst, who sees the "totality of data as a probability of success increase lever," reiterates an Overweight rating on Scholar Rock shares.
👍️0
georgie18 georgie18 3 years ago
SRRK...$48.08...Back in on the Bullish Engulfing Candle on the Overbought Retrace...Psar will flip to a Bullish Buy Position this week...

Break/Hold $52 with no topside resistance and we make a run at $75/$100 range on this Blue Skies Chart...imo...we shall see...

Chart..https://schrts.co/wGhsGXPZ

georgie18 Wednesday, 10/28/20 06:38:13 AM
Re: None 0
Post #
3
of 21
SRRK...$34.85...in the PM...on this Blue Skies Chart set up...no topside resistance here...
[6:37 AM]
georgie1808/10/2020
SRRK...$14.22...Hod...just keeps gradually moving up off my $11.29 alert...I think $31 is coming here...we shall see...

👍️0
georgie18 georgie18 3 years ago
SRRK...$46.91...Looking for the Upper Bollie breakout...on the Pole N Flag Breakout...imo...we shall see...

georgie18 Tuesday, 11/24/20 07:16:17 AM
Re: georgie18 post# 3 0
Post #
19
of 20
SRRK...$41.40...Bullish Pole N Flag Breakout setting up here as the Bollies start to Squeeze here...Looking for $75/$100 move...imo...we shall see...

Chart... http://schrts.co/rzYtEpQt

georgie18 Wednesday, 10/28/20 06:38:13 AM
Re: None 0
Post #
3
of 19
SRRK...$34.85...in the PM...on this Blue Skies Chart set up...no topside resistance here...
[6:37 AM]
georgie1808/10/2020
SRRK...$14.22...Hod...just keeps gradually moving up off my $11.29 alert...I think $31 is coming here...we shall see...
👍️0
georgie18 georgie18 3 years ago
SRRK...$46.91...on the Upper Bollie Break...
👍️0
georgie18 georgie18 3 years ago
SRRK...$41.40...Bullish Pole N Flag Breakout setting up here as the Bollies start to Squeeze here...Looking for $75/$100 move...imo...we shall see...

Chart... http://schrts.co/rzYtEpQt

georgie18 Wednesday, 10/28/20 06:38:13 AM
Re: None 0
Post #
3
of 19
SRRK...$34.85...in the PM...on this Blue Skies Chart set up...no topside resistance here...
[6:37 AM]
georgie1808/10/2020
SRRK...$14.22...Hod...just keeps gradually moving up off my $11.29 alert...I think $31 is coming here...we shall see...

👍️0
JohnQQ JohnQQ 3 years ago
https://finance.yahoo.com/m/9fae2849-74b9-3d45-9293-6540a970693d/2-top-biotech-stocks-from-the.html
👍️0
JohnQQ JohnQQ 3 years ago
New Seeking Alpha Article
👍️0
JohnQQ JohnQQ 3 years ago
SOME SHORTS DID NOT CLOSE HAHA !

https://seekingalpha.com/article/4384830-scholar-rock-is-phase-2-1-billion-is-too-expensive
👍️0
Pedro2004 Pedro2004 3 years ago
I think the run is over.
They just did a Private Placement at $39.00
Let's see what happens in a few months.
👍️0
TheFinalCD TheFinalCD 3 years ago
$41's wow CONGRATS to anyone making money here


SRRk
👍️0
Pedro2004 Pedro2004 3 years ago
Thanks. This company woke up very quickly.
👍️0
ClayTrader ClayTrader 3 years ago
* * $SRRK Video Chart 10-29-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
georgie18 georgie18 3 years ago
SRRK...$43.43...CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Scholar Rock Holding Corporation (Nasdaq: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced the pricing of an underwritten public offering of 2,948,718 shares of its common stock at a public offering price of $39.00 per share...

No position at the moment after the $11 range alert ran to $45 range...
👍️0
ClayTrader ClayTrader 3 years ago
* * $SRRK Video Chart 10-28-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
easymoney easymoney 3 years ago
Sold before eod lol well traded like 10 times today and yesterday
👍️0
PAC PAC 3 years ago
Book runners pumping to short shares to absorb the offering at a lower price. $150m worth will be a lot of shares for them to accumulate short. that's why the run up and squeeze.

Seems like co. desperate for money bc the results were interim of phase 2. maybe get a pricing below $30
👍️0
TheFinalCD TheFinalCD 3 years ago
45.30 CONGRATS!!!


SRRK
👍️0
TheFinalCD TheFinalCD 3 years ago
SRRK $40 BROKE!!


42.11 HOD


👍️0
Pedro2004 Pedro2004 3 years ago
Let's see if this breaks $40.00 today.
👍️0
Pedro2004 Pedro2004 3 years ago
I agree. I was watching this since yesterday, In at 23, out at 24.50.

👍️0
georgie18 georgie18 3 years ago
SRRK...$34.85...in the PM...on this Blue Skies Chart set up...no topside resistance here...
[6:37 AM]
georgie1808/10/2020
SRRK...$14.22...Hod...just keeps gradually moving up off my $11.29 alert...I think $31 is coming here...we shall see...
👍️0
Jornwell Jornwell 3 years ago
Dilution always kills at this pps, look at DRYS I would stay away for now unless TA shows uptick in buying activity
👍️0
ASPD_Capital ASPD_Capital 3 years ago
Spinal Muscular Atrophy (SMA) affects between 1 in 6,000 to 1 in 10,000 depending on type. $SRRK tested SRK-015 on 58 people and they improved a little. Still a ways to go for a marginally rare disease. At the same time, the company announced intent to issue $150 million worth of new shares at an undisclosed price with a $22.5 million option. Please post your thoughts on whether this price action continues or if dilution and loss of interest tanks it. I'm definitely torn. LOL
👍️0

Your Recent History

NASDAQ
SRRK
Scholar Rock
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved